NEW YORK, NY – Crohn’s disease and ulcerative colitis, also known as inflammatory bowel disease (IBD), affect millions of Americans and can significantly impair patient quality of life.
New York, NY -- The Crohn’s & Colitis Foundation (the Foundation) announced today that it received a $3 million donation from Jonathan D. Rose, MD, PhD, to support two major Foundation research programs: IBD-SIRCQ, a national, prospective surgical cohort, and the Jonathan D.
NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that it is presenting its Uniting to Care & Cure Awards to 16 healthcare providers from across the country in recognition of their work to help find cures for inflammatory bowel disease (IBD) and improve the quality of life o
New York, NY – For Crohn’s disease patients with mild-to-moderate symptoms, a Mediterranean style diet and the Specific Carbohydrate Diet™ appear to improve symptoms and quality of life, according to a new study published in
The Crohn’s & Colitis Foundation announced today that it has received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to improve the urgent care management of Crohn’s disease through IBD Qorus®, the Foundation’s flagship quality of care program.
Progenity, Inc., a biotechnology company with an established track record of success developing and commercializing molecular testing products, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to further develop Progenity’s first-in-class oral Drug Delivery System (DDS) for delivery of targeted therapeutics for inflammatory bowel disease (IBD).
NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that Dr. Brent Polk (University of California San Diego) has been appointed Chair of its national Board of Trustees, and that three new trustees have been elected to the Board.
NEW YORK, NY – The Crohn's & Colitis Foundation, the leading non-profit dedicated to finding cures for inflammatory bowel disease (IBD) and improving patient quality of life, launched a new public service announcement (PSA) campaign to increase familiarity with the symptoms of Crohn’s disease
The Crohn's and Colitis Foundation enters partnership with LifeArc to develop first clinical tests to predict disease course and response to treatment in pediatric Crohn's patients.
NEW YORK, NY – The Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer Inc., has announced the results of a request for proposal (RFP) to reduce health disparities that exist around vaccine usage and health maintenance in patients with inflammatory bowel disease (IBD).
The American College of Gastroenterology (ACG) and The Crohn’s & Colitis Foundation (the Foundation) are proud to announce their joint publication of “Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States” in both
August 25, 2020
Browser not supported
Your Internet Explorer is outdated. For optimal security settings and a better experience on our site, try switching to one of these options: